Innovid Corp.
CTV · NYSE
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $38 | $38 | $37 | $39 |
| % Growth | 0.8% | 3.3% | -4.9% | – |
| Cost of Goods Sold | $9 | $9 | $11 | $13 |
| Gross Profit | $29 | $29 | $25 | $26 |
| % Margin | 76.7% | 76% | 69.1% | 67.1% |
| R&D Expenses | $7 | $7 | $6 | $6 |
| G&A Expenses | $9 | $9 | $11 | $11 |
| SG&A Expenses | $21 | $22 | $22 | $22 |
| Sales & Mktg Exp. | $12 | $12 | $12 | $11 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $28 | $29 | $28 | $28 |
| Operating Income | $1 | -$3 | -$3 | -$3 |
| % Margin | 3.6% | -7.4% | -8.4% | -6.6% |
| Other Income/Exp. Net | -$2 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$3 | -$3 | -$2 |
| Tax Expense | -$5 | $8 | $3 | -$0 |
| Net Income | -$0 | -$11 | -$6 | -$2 |
| % Margin | -0.7% | -27.8% | -17% | -4.3% |
| EPS | 0.032 | -0.073 | -0.044 | -0.012 |
| % Growth | 143.7% | -66.2% | -271.2% | – |
| EPS Diluted | 0.031 | -0.073 | -0.044 | -0.012 |
| Weighted Avg Shares Out | 147 | 145 | 142 | 141 |
| Weighted Avg Shares Out Dil | 153 | 145 | 142 | 141 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $3 | $4 |
| EBITDA | $1 | $0 | -$0 | $2 |
| % Margin | 3.6% | 0.1% | -1.3% | 4.2% |